Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The mechanisms of thrombotic risk induced by hormone replacement therapy.

Maturitas - 31 Oct 2001

Cano A, Van Baal W M

Abstract excerpt

OBJECTIVES: To review the available information on the action of hormones on the mechanisms involved in thrombotic risk. RESULTS AND CONCLUSIONS: Thrombosis plays a crucial role in the genesis and progression of both coronary heart disease (CHD) and venous thromboembolic disease (VTED), the two main forms of cardiovascular disease. Two main determinants of the thromboembolic phenotype, hypercoagulable state and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteriosclerosis
Share to Blood Platelets
Share to Endothelium, Vascular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Replacement Therapy

Share to Estrogens

Share to Hemostasis

Share to Postmenopause

Share to Venous Thrombosis

Source

Identifiers

PMID: 11684370
DOI: 10.1016/s0378-5122(01)00270-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The mechanisms of thrombotic risk induced by hormone replacement therapy.PMID 11684370Read ↗

Estrogen therapy and thrombotic risk.Semantic proximity Read ↗

Oral contraceptives and the risk of thrombosis and atherosclerosis.Semantic proximity Read ↗

Venous thrombosis and women's health : identification of risk factors and long terms effectsSemantic proximity Read ↗

Oral contraceptives, hormone therapy and cardiovascular risk.Semantic proximity Read ↗

The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.Semantic proximity Read ↗

Ageing, oestrogen, platelets and thrombotic risk.Semantic proximity Read ↗

“Unraveling the Clot-Miscarriage Nexus: Mechanisms, Management, and Future Directions in Thrombosis-Related Recurrent Pregnancy Loss”Semantic proximity Read ↗

Hormonal contraception, thrombosis and age.Semantic proximity Read ↗

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.Semantic proximity Read ↗

Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis.Semantic proximity Read ↗

Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.Semantic proximity Read ↗

Hutchinson–Gilford Progeria Syndrome: Cardiovascular Pathologies and Potential TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.